Page last updated: 2024-08-25

sesamin and ER-Negative PR-Negative HER2-Negative Breast Cancer

sesamin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kongtawelert, P; Phitak, T; Pothacharoen, P; Shwe, TH; Wudtiwai, B	1

Other Studies

1 other study(ies) available for sesamin and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin. International immunopharmacology, 2020, Volume: 86 Topics: Adenocarcinoma; B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Dioxoles; Female; Humans; Janus Kinases; Lignans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT Transcription Factors; Triple Negative Breast Neoplasms; Up-Regulation	2020

Article

Year

Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin.

International immunopharmacology, 2020, Volume: 86

Topics: Adenocarcinoma; B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Dioxoles; Female; Humans; Janus Kinases; Lignans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT Transcription Factors; Triple Negative Breast Neoplasms; Up-Regulation

2020